Gastric Cancer
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 7, 2005; 11(21): 3227-3233
Published online Jun 7, 2005. doi: 10.3748/wjg.v11.i21.3227
Table 1 Correlation of bFGF and MMP-9 mRNA expression and pathological parameters in 105 gastric carcinoma cases.
GroupsnbFGFmRNA
rsPMMP-9mRNA
rsP
-++++++-++++++
Growth pattern0.3240.0010.2670.006
Expansive4827885271290
Infiltrative5714720161713216
Invasive depth0.2110.0310.3350.001
T1-T24431553261161
T3-T461101023181814245
Vessel invasion0.5790.0010.2090.032
Absent292522017741
Present76161326212718265
Lymph node metastasis0.4050.0010.3430.001
Absent352544221671
Present70161124192319235
Distant metastasis0.4740.0010.4680.001
Absent63371484409104
Present42412017416202
Table 2 MVD in different gastric carcinoma pathological parameters (number/0.72 mm2, mean±SD).
GroupsnMVDtP
Tumor differentiation0.9650.337
High-moderate6338.33±14.83
Low-undifferentiated4241.09±13.97
Growth pattern10.1050.001
Expansive4834.70±15.23
Infiltrative5743.42±12.64
Invasive depth5.9610.001
T1-T24430.84±13.66
T3-T46145.64±11.69
Vessel invasion7.3940.001
Absent2925.69±10.11
Present7644.68±12.33
Lymph node metastasis3.8190.01
Absent3527.07±11.33
Present7045.62±11.69
Distant metastasis10.5780.001
Absent6331.30±12.97
Present4252.19±6.42
Table 3 Correlation of MVD with bFGFmRNA , MMP-9mRNA expression in 105 cases of gastric cancer.
GroupsnMVD (number/0.72 mm2)tP
bFGFmRNA3.2070.002
+-+++6446.09±11.52
-4129.41±12.47
MMP-mRNA7.3050.001
+-+++6143.75±13.41
-4433.45±13.92
Table 4 Correlation of MVD, bFGF, and MMP-9mRNA expression with survival rate.
GroupsnMean survival time (mo)Five-year survival rate (%)P
MVD0.035
<39.56770.42±5.8263.30 (42/67)
≥39.53818.57±3.7616.95 (6/38)
bFGFmRNA0.001
-41118.0±46.5287.06 (38/41)
+-+++6433.06±3.5716.21 (10/64)
MMP-mRNA0.002
-44107.2±87.2081.82 (36/44)
+-+++6142.42±8.2516.02 (9/61)